Autopsy report · NCT03656627

Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“low accrual”

The sponsor’s own words in the registry.

Life of this trial

Registered 10 months before it started.
Ran for about 1 year 9 months before it stopped.
7 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Alliance Foundation Trials, LLC.
Sponsor type: University, hospital or other
Conditions: Autoimmune Diseases; Non-small Cell Lung Cancer; Rheumatoid Arthritis; Psoriasis; Giant Cell Arteritis; Polymyalgia Rheumatica
Interventions: Nivolumab
Participants: 7
Sites: 9
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.